| Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain D Ito, K Tanaka, S Suzuki, T Dembo, Y Fukuuchi Stroke 32 (5), 1208-1215, 2001 | 712 | 2001 |
| Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan S Suzuki, N Ishikawa, F Konoeda, N Seki, S Fukushima, K Takahashi, ... Neurology 89 (11), 1127-1134, 2017 | 399 | 2017 |
| Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy Y Watanabe, A Uruha, S Suzuki, J Nakahara, K Hamanaka, K Takayama, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (10), 1038-1044, 2016 | 346 | 2016 |
| Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects S Suzuki, K Tanaka, N Suzuki Journal of Cerebral Blood Flow & Metabolism 29 (3), 464-479, 2009 | 334 | 2009 |
| Blockade of interleukin‐6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons T Yamashita, K Sawamoto, S Suzuki, N Suzuki, K Adachi, T Kawase, ... Journal of neurochemistry 94 (2), 459-468, 2005 | 249 | 2005 |
| Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients S Suzuki, A Nishikawa, M Kuwana, H Nishimura, Y Watanabe, ... Orphanet journal of rare diseases 10, 1-9, 2015 | 243 | 2015 |
| Autoimmune targets of heart and skeletal muscles in myasthenia gravis S Suzuki, K Utsugisawa, H Yoshikawa, M Motomura, S Matsubara, ... Archives of Neurology 66 (11), 1334-1338, 2009 | 210 | 2009 |
| Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis M Seki, S Suzuki, T Iizuka, T Shimizu, Y Nihei, N Suzuki, J Dalmau Journal of Neurology, Neurosurgery & Psychiatry 79 (3), 324-326, 2008 | 205 | 2008 |
| Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats S Suzuki, K Tanaka, S Nogawa, T Dembo, A Kosakai, Y Fukuuchi Experimental neurology 170 (1), 63-71, 2001 | 197 | 2001 |
| Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia O Herrmann, V Tarabin, S Suzuki, N Attigah, I Coserea, A Schneider, ... Journal of Cerebral Blood Flow & Metabolism 23 (4), 406-415, 2003 | 194 | 2003 |
| Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial S Misawa, S Kuwabara, Y Sato, N Yamaguchi, K Nagashima, K Katayama, ... The Lancet Neurology 17 (6), 519-529, 2018 | 180 | 2018 |
| Sarcoplasmic MxA expression: a valuable marker of dermatomyositis A Uruha, A Nishikawa, RS Tsuburaya, K Hamanaka, M Kuwana, ... Neurology 88 (5), 493-500, 2017 | 173 | 2017 |
| Skeletal muscle involvement in antisynthetase syndrome E Noguchi, A Uruha, S Suzuki, K Hamanaka, Y Ohnuki, J Tsugawa, ... JAMA neurology 74 (8), 992-999, 2017 | 160 | 2017 |
| Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats S Suzuki, K Tanaka, S Nogawa, E Nagata, D Ito, T Dembo, Y Fukuuchi Journal of Cerebral Blood Flow & Metabolism 19 (11), 1256-1262, 1999 | 149 | 1999 |
| Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system … A Yamane, T Mori, S Suzuki, A Mihara, R Yamazaki, Y Aisa, T Nakazato, ... Biology of Blood and Marrow Transplantation 13 (1), 100-106, 2007 | 143 | 2007 |
| Upregulation of oligodendrocyte progenitor cells associated with restoration of mature oligodendrocytes and myelination in peri-infarct area in the rat brain K Tanaka, S Nogawa, S Suzuki, T Dembo, A Kosakai Brain research 989 (2), 172-179, 2003 | 141 | 2003 |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study V Bril, A Drużdż, J Grosskreutz, AA Habib, R Mantegazza, S Sacconi, ... The Lancet Neurology 22 (5), 383-394, 2023 | 137 | 2023 |
| Three types of striational antibodies in myasthenia gravis S Suzuki, K Utsugisawa, Y Nagane, N Suzuki Autoimmune Diseases 2011 (1), 740583, 2011 | 128 | 2011 |
| Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study JF Howard, S Bresch, A Genge, C Hewamadduma, J Hinton, Y Hussain, ... The Lancet Neurology 22 (5), 395-406, 2023 | 122 | 2023 |
| Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome S Suzuki, YK Hayashi, M Kuwana, R Tsuburaya, N Suzuki, I Nishino Archives of neurology 69 (6), 728-732, 2012 | 118 | 2012 |
Ichizo NISHINODirector, Department of Neuromuscular Research, National Institute of Neuroscience, NCNP確認したメール アドレス: ncnp.go.jp